Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
D FennellyD Spriggs

Abstract

Paclitaxel has shown significant activity in advanced ovarian cancer. In vitro studies with paclitaxel have suggested that fractionated brief infusion schedules may be more effective than the standard 24-hour infusion. We commenced a phase I evaluation of escalating-dose paclitaxel (40, 50, 60, 80, 100 mg/m2) administered weekly as a 1-hour infusion in patients with recurrent ovarian cancer. All patients had received prior paclitaxel and cisplatin therapy. All patients received standard premedication. Eighteen patients are assessable on this phase I study. The mean age was 54 years (range, 48 to 74). The median number of prior chemotherapy regimens was three (range, two to five). The mean paclitaxel-free interval was 10.1 months (range, 1 to 24). A total of 194 cycles of therapy were administered, with a mean of 10 (range, one to 12) per patient. No mucositis or grade III neuropathy was seen. Alopecia occurred in one out of 18 assessable patients. The mean neutrophil nadir was 4.0 x 10(9)/L. At the top dose level (100 mg/m2) delivered, dose-intensity was 90.75% of that planned and greater than two fold the standard dose-intensity. Partial responses were seen in four of 13 assessable patients (30%). Two patients with progression...Continue Reading

Citations

Dec 21, 2000·Current Oncology Reports·A A Garcia
Sep 27, 2002·The Oncologist·Charles J Dunton
Aug 28, 2003·International Journal of Urology : Official Journal of the Japanese Urological Association·Hidetoshio KurumaShiro Baba
Nov 25, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Yukihiko TokunagaKiyoshi Ohsumi
Nov 25, 2003·Cancer Investigation·David M BorutaLinda Van Le
Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M E L van der BurgJ Verweij
Mar 25, 2006·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Shuichi HironakaYusuke Onozawa
Jun 17, 2006·Cancer Investigation·Diana StempakSylvain Baruchel
Mar 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A L LeiserC Aghajanian
Feb 19, 2008·Expert Review of Anticancer Therapy·Maurie Markman
Jun 11, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angiolo GadducciUNKNOWN Members of the After-6 Italian Cooperative Group
Jul 8, 2011·Archives of Gynecology and Obstetrics·Gianmaria MioloAndrea Veronesi
Feb 1, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Saul Eugene RivkinErin D Ellis
Aug 27, 2019·Expert Opinion on Investigational Drugs·S Percy IvyElise C Kohn
Jul 28, 2001·American Journal of Clinical Oncology·C KouroussisV Georgoulias
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K KellyH Scher
Aug 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D HainsworthF A Greco
Dec 9, 2003·British Journal of Cancer·J P Guastalla, V Diéras
Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P A Vasey
Jan 22, 2005·Cancer Chemotherapy and Pharmacology·Aristides PolyzosVassilios Georgoulias
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M S ManoM Piccart
Jul 16, 2005·Hematology·Soon Thye Lim, Alexandra M Levine
Jan 17, 2004·Drugs in R&D·Lazzaro RepettoLucia Del Mastro
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S PecorelliG Favalli
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R SpriggsMark Hanly
Mar 6, 2007·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Michiya KobayashiKazuhiro Hanazaki
Apr 14, 2006·The New England Journal of Medicine·Carolyn N KrasnerEsther Oliva
Nov 30, 2006·British Journal of Cancer·E MochikiUNKNOWN North Kanto Gastric Cancer Study Group
Aug 5, 2010·Nature Reviews. Clinical Oncology·Richard D BairdStan B Kaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A D SeidmanL Norton
Gan to kagaku ryoho. Cancer & chemotherapy
Hidehiro KawagoeAkitsu Tsunawaki
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Tariq Nadeem AnsariAbdus Samad Syed
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J D HainsworthF A Greco
© 2022 Meta ULC. All rights reserved